Showing results (141-150 of 191) with videos related to

Sort By:
Pageof 20
Haematologica|June 1, 2010
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphomaSilvia Zibellini, Daniela Capello, Francesco Forconi, et al.
Blood|April 13, 2010
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemiaRossana Maffei, Silvia Martinelli, Rita Santachiara, et al.
Hematological Oncology|July 21, 2019
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD NetworkIrene Della Starza, Marzia Cavalli, Lucia Anna De Novi, et al.
Blood|June 16, 2010
Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemiaFrancesco Buccisano, Luca Maurillo, Alessandra Spagnoli, et al.
Blood|November 15, 2011
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemiaDavide Rossi, Silvia Rasi, Giulia Fabbri, et al.
Haematologica|December 31, 2011
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genesSimone Ferrero, Daniela Capello, Mirija Svaldi, et al.
Blood|April 8, 2006
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Francesco Buccisano, et al.
Blood|February 7, 2012
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemiaDavide Rossi, Marco Fangazio, Silvia Rasi, et al.
Cancers|April 12, 2022
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 PathwayFederica Tonon, Maja Cemazar, Urska Kamensek, et al.
Blood|November 1, 2011
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractorinessDavide Rossi, Alessio Bruscaggin, Valeria Spina, et al.
Pageof 20